Alpha Teknova Q2 2021 revenue up 38% to $8.3M; net loss of $2.3M vs prior-year profit

Alpha Teknova, Inc.

2021-Q2 EPS reported -$0.73 revenue$17,391,000

Total revenue $8.3M, +38% YoY; Lab Essentials revenue $6.5M (+46%), Clinical Solutions $1.6M (+32%).
Gross margin fell to 40.4% from 57.4%; cost of sales included $0.7M one-time reserve for excess Sample Transport inventory.
Net loss attributable to common stockholders $2.3M ($0.52/share) vs net income of $0.1M ($0.02/share) in Q2 2020.
Adjusted EBITDA negative $1.5M vs positive $1.2M a year ago; cash position $108M after $99.1M IPO net proceeds.
Began construction on new GMP facility in Hollister, CA; appointed three new independent directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.